中文 | English
Return
Total: 290 , 1/29
Show Home Prev Next End page: GO
Author:(Duk Hee KANG)

1.Concentrations of IL-6, TNF-alpha, Phospholipid and CA125 in Dialysis Fluid during the Course of CAPD Peritonitis.

Duk Hee KANG

Korean Journal of Nephrology 1998;17(5):771-778

2.Prostaglandin Synthesis of Cultured Human Peritoneal Mesothelial Cells: Effect of Cytokine Stimulation and Cyclo-oxygenase Inhibitor.

Duk Hee KANG

Korean Journal of Nephrology 1999;18(6):869-876

4.Oncogenous Rickets: Report of Two Cases

Duk Yong LEE ; Hee Joong KANG ; Choong Hee WON

The Journal of the Korean Orthopaedic Association 1986;21(3):507-514

5.Case of Pyriform Sinus Fistula Treated by Injection of Histoacryl.

Bo Hoon KANG ; In Gyung CHOI ; Duk Hee KIM

Journal of Korean Society of Pediatric Endocrinology 2004;9(1):76-80

6.Growth Status in Children with Type 1 and 2 Diabetes Mellitus.

Du Cheol KANG ; Eun Gyeog YOO ; Duk Hee KIM

Journal of Korean Society of Pediatric Endocrinology 2002;7(1):61-68

7.Congenital Ball-and-Socket Ankle Joint: A Case Report

Se Hyun CHO ; Duk Yong LEE ; Hee Joong KANG

The Journal of the Korean Orthopaedic Association 1985;20(1):201-204

8.Basal Serum Luteinizing Hormone Levels as a Prognostic Indicator of Ovarian Response to Controlled Ovarian Hyperstimulation.

Chung Hoon KIM ; Hee Dong CHAE ; Byung Moon KANG ; Yoon Seok CHANG ; Eun Hee KANG ; Mi Duk SEO ; Cheon HWANGBO

Korean Journal of Obstetrics and Gynecology 1999;42(8):1706-1712

9.Does Hyperuricemia Play a Causative Role in the Development and/or Aggravation of Renal, Cardiovascular and Metabolic Disease?.

Duk Hee KANG

Korean Journal of Medicine 2011;80(5):524-528

10.Anticardiolipin Antibody (ACA) and Lupus Anticoagulant (LA): Association with Vascular Access Occlusion in Hemodialysis (HD) Patients.

Duk Hee KANG ; Seung Ki RYU ; Sung Nam KIM ; Kyun Il YOON ; Yoon Ha LEE

Korean Journal of Medicine 1997;53(5):661-670

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 290 , 1/29 Show Home Prev Next End page: GO